David J Serisier
Affiliation: South Brisbane
- Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosisDavid J Serisier
Adult Cystic Fibrosis Unit, Southampton University Hospital NHS Trust, Southampton, Hampshire, UK
Pediatr Pulmonol 35:463-6. 2003..DSST is a form of "whole" sputum sensitivity testing that provides information on antibiotic synergy, and may more accurately reflect in vivo antibiotic sensitivity patterns in cystic fibrosis...
- Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trialDavid J Serisier
Department of Respiratory Medicine, Level 9, Mater Adult Hospital, Raymond Terr, South Brisbane, Queensland 4101, Australia
JAMA 309:1260-7. 2013..Macrolide antibiotics such as erythromycin may improve clinical outcomes in non-cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are poorly defined...
- Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumoniaDavid J Serisier
Department of Respiratory Medicine, Mater Adult Hospital, Auchenflower, Queensland, Australia
Respirology 18:291-6. 2013..Until recently, the Australasian Therapeutic Guidelines has recommended the use of the Pneumonia Severity Index (PSI) in spite of poor user-friendliness...
- Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testingD J Serisier
Department of Respiratory Medicine and University of Qld, Mater Adult Hospital Infection, Inflammation and Immunity Program, Mater Medical Research Institute, Lvl 9, Raymond Tce, South Brisbane, QLD, Australia
Eur J Clin Microbiol Infect Dis 31:3211-6. 2012..Future studies will determine whether these potential theoretical advantages translate into clinical benefits...
- Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacinD J Serisier
Dept of Respiratory Medicine, University of Queensland, South Brisbane, Queensland, Australia
Drugs Today (Barc) 48:339-51. 2012....
- Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbationsD J Serisier
Dept of Respiratory Medicine, Lvl 9, Mater Adult Hospital, Raymond Tce, South Brisbane, QLD 4101, Australia
Respir Med 105:946-9. 2011..Widespread, injudicious use of long-acting macrolides, particularly azithromycin, risks significantly increasing population antimicrobial resistance...
- Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputumDavid J Serisier
Department of Respiratory Medicine, Mater Adult Hospital, Brisbane, Australia
Respir Res 10:63. 2009..We therefore reassessed this question using whole sputum macrorheology. Additionally, we wished to further explore the relationships between sputum rheology, inflammation and infection...
- Effect of albuterol on maximal exercise capacity in cystic fibrosisDavid J Serisier
DM, Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, QLD 4101, Australia
Chest 131:1181-7. 2007..We tested the hypothesis that inhaled albuterol would improve maximal exercise performance in CF subjects with airflow obstruction, as a result of acute bronchodilation...
- Effect of a simple educational intervention on the hospital management of community-acquired pneumoniaDavid J Serisier
Department of Respiratory Medicine, Mater Adult Hospital, Brisbane, Queensland, Australia
Respirology 12:389-93. 2007..While quality improvement projects have been linked to better CAP management and outcomes, there are limited data evaluating simple and achievable interventions...
- Bacterial activity in cystic fibrosis lung infectionsGeraint B Rogers
Department of Life Sciences, King s College London, London, UK
Respir Res 6:49. 2005..The aim of this study was to determine whether the species present were active and, as such, worthy of further investigation as potential pathogens...
- Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolidDavid J Serisier
J Cyst Fibros 3:61. 2004